Not applicableStudy completedNCT02786186What this trial is testingA Registry of Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Novartis Pharmaceuticals 2,376
Not applicableStudy completedNCT01084668What this trial is testingQuality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic DrugsWho this might be right forPsoriasis Chronic Abbott 46
Large-scale testing (Phase 3)Study completedNCT01690299What this trial is testingPhase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisWho this might be right forPsoriasisPsoriatic Arthritis Amgen 250
Not applicableStudy completedNCT05155098What this trial is testing2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial SpondyloarthritisWho this might be right forModerate to Severe Plaque PsoriasisPsoriatic ArthritisAnkylosing Spondylitis+1 more Novartis Pharmaceuticals 127
Post-approval studies (Phase 4)Ended earlyNCT02408159What this trial is testingVaricella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapyWho this might be right forPsoriasis Innovaderm Research Inc. 3
Post-approval studies (Phase 4)UnknownNCT03553433What this trial is testingApremilast Treatment for Pruritus and Quality of Life in Scalp PsoriasisWho this might be right forPsoriasis of ScalpPsoriasis Vulgaris University of Zurich 90
Post-approval studies (Phase 4)Study completedNCT02400749What this trial is testingApremilast in Palmo-Plantar PsoriasisWho this might be right forPalmo-plantar Psoriasis Innovaderm Research Inc. 100
Testing effectiveness (Phase 2)Study completedNCT05375955What this trial is testingLearn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.Who this might be right forAtopic DermatitisPlaque Psoriasis Pfizer 263
Early research (Phase 1)Study completedNCT02397382What this trial is testingPharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With PsoriasisWho this might be right forPsoriasis Janssen Research & Development, LLC 16
Testing effectiveness (Phase 2)Study completedNCT02131324What this trial is testingDFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Promius Pharma, LLC 50
Not applicableEnded earlyNCT00402818What this trial is testingRESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment OptimizationWho this might be right forPlaque Psoriasis Merck KGaA, Darmstadt, Germany 294
Testing effectiveness (Phase 2)Study completedNCT05772520What this trial is testingThe Efficacy and Safety of TLL018 in Moderate-to-severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Hangzhou Highlightll Pharmaceutical Co., Ltd 82
Large-scale testing (Phase 3)Active Not RecruitingNCT06550076What this trial is testingTAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 2,099
Post-approval studies (Phase 4)Study completedNCT04306315What this trial is testingAdjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body WeightWho this might be right forPsoriasis Vulgaris LEO Pharma 385
Not applicableStudy completedNCT04398732What this trial is testingStudy to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis PatientsWho this might be right forPlaque Psoriasis Pfizer 486
Post-approval studies (Phase 4)UnknownNCT00707070What this trial is testingCombining Acitretin and Efalizumab in the Therapy of Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Universita di Verona 100
Testing effectiveness (Phase 2)Study completedNCT01045577What this trial is testingA Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis AB Science 25
Not applicableStudy completedNCT00800982What this trial is testingOpen Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type PsoriasisWho this might be right forPsoriasis University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT02785185What this trial is testingSafety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03329885What this trial is testingExperimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious PsoriasisWho this might be right forRheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more Bristol-Myers Squibb 38